Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

68.42
Delayed Data
As of Mar 22
 +0.66 / +0.97%
Today’s Change
47.88
Today|||52-Week Range
72.58
+15.59%
Year-to-Date
XBI Regular Dividend: XBI began trading ex-dividend on 03/17/17. A $0.0197 dividend will be paid to shareholders of record as of 03/21/17.

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Time to Buy Biotech ETFs?
Mar 13 / Zacks.com - Paid Partner Content
 

Performance

1 month-1.85% 3 years+10.58%
3 months+11.99% 5 years+21.58%
1 year+33.20% Since inception+13.92%
Data through 03/22/2017

Quote Details

Previous close$67.76
Open day’s range67.41 – 68.69
Net asset value (NAV)67.68 (03/21/2017)
Daily volume6,780,126
Average volume (3 months)5,916,091
Data as of 7:59pm ET, 03/22/2017

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+21.58%+16.84%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.821.11
Net assets$3.0B$3.0B
Average market cap$4.9B$30.5B
Average P/E--22.3
Dividend / Share--0.32%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CLVS Clovis Oncology Inc3.22%
KITE Kite Pharma Inc3.13%
TSRO TESARO Inc2.94%
ACAD ACADIA Pharmaceuticals Inc2.89%
EXAS Exact Sciences Corp2.83%
INCY Incyte Corp2.69%
EXEL Exelixis Inc2.60%
BLUE bluebird bio Inc2.56%
AMGN Amgen2.50%
ALNY Alnylam Pharmaceuticals Inc2.48%